无功能垂体腺瘤复发及其与性别、大小和激素免疫组化特征的关系
该研究回顾性分析了2000至2014年间在单一垂体神经外科中心接受经蝶手术的410例无功能垂体腺瘤患者的病历,评估肿瘤复发与性别、大小及激素免疫组化特征的关系。结果显示复发与性别和年龄无关,静默型促肾上腺皮质激素腺瘤和巨大腺瘤的复发风险更高(风险比分别为2.45和2.35)。
要点
- 静默型促肾上腺皮质激素腺瘤和巨大腺瘤的复发风险较高(HR分别为2.45和2.35)。
- 肿瘤复发与性别或年龄无关。
- 无功能垂体腺瘤的激素免疫组化特征具有高度异质性,可能具有预后意义。
核心结论
- 无功能垂体腺瘤具有高度异质的激素免疫组化特征,可能具有预后重要性。
- 静默型促肾上腺皮质激素腺瘤和巨大腺瘤的复发率较高。
研究设计与样本
- 回顾性分析2000年至2014年间在单一垂体神经外科中心接受经蝶手术的410例无功能垂体腺瘤患者的病历。
主要发现
- 参与者中女性210例(51.0%)。
- 14.1%为巨大腺瘤。
- 零细胞垂体腺瘤最常见(n=239;58.9%),其次为静默型促性腺激素腺瘤(n=112;27.3%)。
- 零细胞腺瘤在女性中更常见(P=0.008),静默型促性腺激素腺瘤在男性中更常见(P=0.004)。
- 肿瘤复发与性别或年龄无关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumor recurrence or incomplete resection in nonfunctioning pituitary adenomas (NFPAs) is relatively common. However, predictive factors of tumor recurrence in NFPAs are not well established. We evaluated possible factors related to tumor recurrence in a large cohort of NFPAs at a single pituitary neurosurgery center. METHODS: A retrospective analysis was conducted of 410 medical records of patients with NFPAs treated by transsphenoidal surgery between 2000 and 2014. RESULTS: Among the participants, 210 were female (51.0%). A total of 14.1% had giant adenomas. Null-cell pituitary adenomas (n = 239; 58.9%) were the most frequent, followed by silent gonadotroph adenomas (n = 112; 27.3%). Null-cell adenomas were more frequent in women (P = 0.008) and silent gonadotroph adenomas were more frequent in men (P = 0.004). Recurrence was not related to sex or age. Tumor recurrence occurred more often among silent corticotropic adenomas and giant adenomas (hazard ratio 2.45; P < 0.0001 and hazard ratio 2.35; P = 0.001, respectively). Silent thyrotrophic adenoma presented a comparable frequency of recurrence of silent corticotropic adenomas, despite having borderline significance (P = 0.07). CONCLUSIONS: NFPA tumors have a high heterogeneous hormonal profile and may have prognostic importance. Silent corticotropic adenomas and giant adenomas present a high rate of recurrence.
引用
- Batista RL, Trarbach EB, Marques MD, et al. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile. World Neurosurg. 2018. PMID: 30138730. doi:10.1016/j.wneu.2018.08.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。